IRIS
FRANCESCHI, MARIA CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.104
AS - Asia 1.849
EU - Europa 814
SA - Sud America 224
AF - Africa 96
Continente sconosciuto - Info sul continente non disponibili 49
OC - Oceania 2
Totale 5.138
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.039
SG - Singapore 665
CN - Cina 568
VN - Vietnam 278
IE - Irlanda 214
SE - Svezia 210
BR - Brasile 168
HK - Hong Kong 101
TR - Turchia 71
DE - Germania 67
FR - Francia 57
NL - Olanda 49
IT - Italia 48
ZA - Sudafrica 48
FI - Finlandia 43
GB - Regno Unito 42
CA - Canada 37
BD - Bangladesh 34
IN - India 32
RU - Federazione Russa 21
CI - Costa d'Avorio 20
AR - Argentina 15
MX - Messico 12
VE - Venezuela 12
PK - Pakistan 11
PL - Polonia 11
JP - Giappone 9
MA - Marocco 9
EC - Ecuador 8
UA - Ucraina 8
CO - Colombia 7
IL - Israele 7
IQ - Iraq 7
IR - Iran 7
PH - Filippine 7
RO - Romania 7
UZ - Uzbekistan 6
BE - Belgio 5
EG - Egitto 5
EU - Europa 5
ID - Indonesia 5
KG - Kirghizistan 5
AZ - Azerbaigian 4
CL - Cile 4
ES - Italia 4
KE - Kenya 4
LT - Lituania 4
MY - Malesia 4
PY - Paraguay 4
TH - Thailandia 4
BB - Barbados 3
BG - Bulgaria 3
BY - Bielorussia 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
HU - Ungheria 3
JM - Giamaica 3
KR - Corea 3
SA - Arabia Saudita 3
TN - Tunisia 3
TW - Taiwan 3
BO - Bolivia 2
HN - Honduras 2
JO - Giordania 2
KZ - Kazakistan 2
LV - Lettonia 2
PE - Perù 2
PT - Portogallo 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AT - Austria 1
AU - Australia 1
BN - Brunei Darussalam 1
CG - Congo 1
CH - Svizzera 1
CR - Costa Rica 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
FJ - Figi 1
GE - Georgia 1
GR - Grecia 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
PA - Panama 1
SR - Suriname 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.095
Salva come PNG Salva come JPEG
Città #
Chandler 354
Singapore 334
Ashburn 303
Santa Clara 230
Dublin 214
San Jose 155
Beijing 125
Hong Kong 95
Ho Chi Minh City 89
Dearborn 74
Nanjing 62
Shanghai 59
Izmir 54
Hanoi 53
Council Bluffs 49
Johannesburg 48
Boardman 47
Princeton 42
Los Angeles 37
Dallas 36
Lauterbourg 36
Helsinki 34
Munich 33
Shenyang 32
Wilmington 27
New York 23
Kunming 21
Nanchang 21
Abidjan 20
Hebei 20
Jiaxing 18
San Mateo 18
Da Nang 17
Frankfurt am Main 17
Moscow 16
Tianjin 15
Changsha 14
Guangzhou 13
Toronto 13
Phoenix 11
São Paulo 11
Columbus 10
Jinan 10
Ann Arbor 9
Buffalo 9
Kocaeli 9
Tokyo 9
Turku 9
Biên Hòa 8
Hangzhou 7
Hefei 7
Orem 7
Pune 7
Seattle 7
Augusta 6
Bremen 6
Brooklyn 6
Cambridge 6
Chennai 6
Fremont 6
Stockholm 6
Timisoara 6
Warsaw 6
Baghdad 5
Belo Horizonte 5
Brussels 5
Draper 5
Edinburgh 5
Grafing 5
Haiphong 5
Hải Dương 5
London 5
Milan 5
Norwalk 5
Tashkent 5
Andover 4
Atlanta 4
Baku 4
Bexley 4
Bishkek 4
Boston 4
Can Tho 4
Cotia 4
Leawood 4
Montreal 4
Mumbai 4
Nairobi 4
Ningbo 4
Parma 4
Rio de Janeiro 4
Rome 4
Salvador 4
Shijiazhuang 4
Taizhou 4
Uberlândia 4
Wuhan 4
Asunción 3
Bangkok 3
Brasília 3
Bridgetown 3
Totale 3.208
Salva come PNG Salva come JPEG
Nome #
Cure of Helicobacter pylori infection in the elderly: effects of eradication on gastritis and serological markers 169
Helicobacter pylori infection in asymptomatic elderly subjects living at home or in a nursing home: effects on gastric function and nutritional status 168
Comparison of three different therapeutic regimens for eradicating Helicobacter pylori 168
10 Day bismuth-based quadruple therapy for HP eradication in comparison with other therapies in a population with high clarithromycin resistance in northeast Italy 159
P.02.8: Chronic Atrophic Gastritis is Related with an Increased Risk for Cardiovascular Diseases, Assessed by Homocysteine Serum Levels Determination 148
P.02.5: PPI Test for Diagnosis of Body Atrophic Gastritis: A Prospective Study 148
PA.28 SERUM PEPSINOGEN I AS NON INVASIVE MARKER OF GASTRIC ACID SECRETION 144
PA.7 CLINICAL VARIABILITY IN THE PRESENTATION OF THE GASTROESOPHAGEAL REFLUX DISEASE BEFORE THE HP ERA (STUDY FROM 1975 TO 1995) 139
P.01.7: Efficacy of PPIS and H-2 Blockers Therapy on Acid Suppression Assessed by Gastrin-17 and Pepsinogen I Serum Levels Determination in Gerd Patients 138
P.01.14: Overweight and Obesity as Risk Factors for Gerd Outcome: A 10 Years Study on a Gerd Population of 365 Patients 138
Rabepmzole in the treatment of non-responders GERD patients: a prospective six-month study 136
P.02.2: Improvement of Symptoms in Patients Affected by Chronic Athrophic Gastritis: A 2 Years Prospective Study by using L-Cysteine (Acetium™) 135
P.02.7: The Branded Proton Pump Inhibitors (PPIS) Increase Levels of Gastrin 17 (G-17) More than the Generic Ones in Dyspeptic Patients from an Italian Primary Care Population 135
Role of Helicobacter pylori infection on NSAIDs-related upper gastrointestinal bleeding in the elderly 133
LONG-TERM TREATMENT WITH MESALAMINE IN DIVERTICULAR DISEASE: A FIVE YEARS FOLLOW-UP STUDY 133
P.02.1: Individual Assessment of Gastric Acid Production by Means of a Non-Invasive Test: Relationship Between Maximal Acid Output and Serum Pepsinogen I Levels in Patients with Different Upper GI Diseases 131
P.02.9: Prevalence of Atrophic Gastritis in General Population: A Gastropanel®-Based Study, Compared with Olga Histological Classification 130
OC.07.3 RECOVERY OF GASTRIC FUNCTION AFTER ACETIUM® ADMINISTRATION: A 2 YEAR PROSPECTIVE STUDY IN PATIENTS WITH CHRONIC, ATROPHIC, BODY GASTRITIS 129
The clinical usefulness of serum pepsinogens, specific IgG anti-HP antibodies and gastrin for monitoring Helicobacter pylori treatment in older people 129
P.02.10: Bismuth-Containing Quadruple Therapy in Patients Infected by Helicobacter Pylori: A First Real Life Italian Experience 123
Serum Pepsinogen II as a non-invasive marker for diagnosis of Helicobacter pylori infection: a prospective study in a cohort of dyspeptic patients 123
Different lansoprazole (LA) dosages in H. pylori (Hp) eradication therapy: A prospective multicenter randomized study comparing 30 MG B.I.D. vs. 15 MG B.I.D 120
OC.09.2: Appropriateness of PPI Administration in the Elderly: Evaluation of Acid Secretion and Atrophic Gastritis by Means of a Non-Invasive Test 120
P.07.2: Natural History of Symptomatic Uncomplicated Diverticular Disease: A 13-Year Prospective Study 119
PO.1 NERD AND ERD: THE SCENARIO IS CHANGING OVER THE TIME? A 30 YEARS FOLLOW UP STUDY 119
La terapia delle malattie acido-correlate nell'anziano 118
P.14.3 A NON-INVASIVE MONITORING OF THE FUNCTIONALITY OF GASTRIC MUCOSA (GASTROPANEL TEST) IN DYSPEPTIC PATIENTS: A PRELIMINARY STUDY 118
P.04.9 DIAGNOSIS OF CHRONIC ATROPHIC GASTRITIS IN PRIMARY CARE SETTING BY MEANS OF GASTROPANEL®: A POPULATION STUDY ON 10,000 CONSECUTIVE PATIENTS 117
P.04.3 SERUM PEPSINOGEN II LEVELS AND IGG ANTI HELICOBACTER PYLORI ANTIBODIES MAY REPRESENT A NON-INVASIVE METHOD FOR THE DIAGNOSIS AND MONITORING OF H PYLORI-RELATED GASTRITIS 115
P.01.5: Serum Pepsinogen II as a Non-Invasive Marker for Diagnosis of Helicobacter Pylori Infection: A Prospective Study in a Cohort of Dyspeptic Patients 115
The cure for Helicobacter pylori ((HP) infection with double or triple omeprazole-based therápies in the elderly: Effects on eradication rate, chronic gastritis and serum anti-HP antibodies and pepsinogens 115
P.16.3 IMPROVEMENT OF APPROPRIATENESS AND REDUCTION OF WAITING LISTS CONCERNING UPPER GI ENDOSCOPY OUTPATIENTS: A SINGLE-CENTRE PROSPECTIVE STUDY 109
P.02.19: Prevalence of H. Pylori Infection, Chronic Atrophic Gastritis and Reflux Disease in a Primary Care Population of North-East Italy with Serum Biomarker Panel (Gastropanel®) 108
P.02.15: The Role of Gastropanel in the Evaluation of the Appropriateness of Proton PUMP Inhibitor (PPI)-Therapy Prescription in a Primary Care Population 97
The efficacy of two doses of omeprazole for short- and long-term peptic ulcer treatment in the elderly 91
Prevalence of H. pylori resistance to antibiotics in North-East Italy: A multicentered study 90
The effect of aging on oro-cecal transit time in normal subjects and patients with gallstone disease 90
P.04.25 ROLE OF CYP2C19*17 AND CYP2C19*2 IN THE RESPONSE TO PROTON PUMP INHIBITORS TREATMENT IN PATIENTS WITH ESOPHAGITIS 89
Role of proton pump inhibitors in the prevention of upper GI bleeding in elderly acute and chronic NSAID users 89
The effect of Helicobacter pylori infection on NSAID-related gastroduodenal damage in the elderly 86
P.17.5 UPPER GI BLEEDING: CLINICAL AND DEMOGRAPHIC FEATURES IN AN ENDOSCOPIC POPULATION STUDY OF NORTH-EAST ITALY 82
P.09.9 DIAGNOSTIC ACCURACY OF AGE AND ALARM SYMPTOMS FOR UPPER GI MALIGNANCY IN PATIENTS WITH DYSPEPSIA IN AN ENDOSCOPIC UNIT 65
null 10
Totale 5.138
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.975
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.975
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022183 0 0 0 9 20 5 0 16 6 17 16 94
2022/2023924 72 114 68 93 58 122 1 84 273 3 32 4
2023/2024249 14 26 4 9 23 56 4 26 12 12 32 31
2024/20251.085 36 52 66 35 139 139 37 46 176 95 80 184
2025/20261.774 200 138 161 144 310 117 160 37 269 132 51 55
2026/2027269 38 102 79 50 0 0 0 0 0 0 0 0
Totale 5.138